BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31989785)

  • 1. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
    Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
    Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
    Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
    J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
    Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
    Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
    Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
    J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
    Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
    J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
    Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
    Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
    Li J; Yue H; Yu H; Lu X; Xue X
    BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts.
    Numakura S; Uozaki H
    Anticancer Res; 2024 Apr; 44(4):1653-1660. PubMed ID: 38537979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
    Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
    Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.
    Xie X; Liu H; Wang Y; Zhou Y; Yu H; Li G; Ruan Z; Li F; Wang X; Zhang J
    Oncotarget; 2016 Jul; 7(29):45837-45848. PubMed ID: 27323852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
    Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
    Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
    Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
    Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
    Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E
    Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
    Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
    Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
    Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
    J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic evaluation of mesenchymal circulating tumor cells in patients with colorectal cancer: Clinical associations and prognostic value.
    Shi DD; Yang CG; Han S; Wang SY; Xiong B
    Oncol Rep; 2020 Aug; 44(2):757-767. PubMed ID: 32627039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.
    Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z
    Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.